Resmetirom – Selective THR-β Agonist | 100mg × 30 Tablets
Resmetirom – Selective THR-β Agonist | 100mg × 30 Tablets | RUO Grade | BlueBiotech®
Thyroid Hormone Receptor-β Modulator for Lipid Metabolism & NASH Research | Made in USA | Research Use Only
| Field Name | Example Value |
|---|---|
| Product Name | Resmetirom – Selective THR-β Agonist |
| Product Code | BB-RUO-RESMETIROM-100 |
| Product Type | Small Molecule – Research Compound |
| Category | Lipid Metabolism / Endocrine Research / NASH / Oral Compounds |
| Manufacturer | BlueBiotech® Research Facility |
| Appearance | Off-white coated tablets |
| Dosage / Units | 100mg per tablet × 30 tablets per bottle |
| Purity | ≥99% (HPLC) |
| Quantity Options | 30 tablets / 60 tablets (by request) |
| Storage | Store in a cool, dry place; protect from light |
| Shelf Life | 24 months unopened |
| Packaging | White bottle with tamper-evident RUO label |
| Manufacturer Origin | USA – Made in USA |
| Use Classification | RUO – Research Use Only (Not for human or veterinary use) |
| Tags | Resmetirom, THR-β agonist, RUO oral tablets, thyroid hormone analog, NASH research, lipid regulation, RUO, BlueBiotech |
Resmetirom (MGL-3196) is a potent and selective thyroid hormone receptor beta (THR-β) agonist, studied for its role in lipid metabolism, liver steatosis reduction, and preclinical models of non-alcoholic steatohepatitis (NASH). This RUO-grade compound is provided as 100mg oral tablets (30 count per bottle) with ≥99% purity. Manufactured in the USA by BlueBiotech®, it is suitable for non-human experimental research involving metabolic and endocrine signaling pathways.
For Research Use Only – Not intended for human or veterinary use.
⚠️This product is labeled for Research Use Only (RUO). Not for human or veterinary therapeutic use.
See RUO Declaration for more info.
Resmetirom – Selective THR-β Agonist | 100mg × 30 Tablets | RUO Grade | BlueBiotech®
Product Overview
Resmetirom (MGL-3196) is a liver-targeted, selective thyroid hormone receptor beta (THR-β) agonist developed for the study of lipid metabolism, hepatic fat regulation, and non-alcoholic steatohepatitis (NASH). Unlike non-selective thyroid analogs, Resmetirom has demonstrated tissue specificity toward liver THR-β isoforms, minimizing off-target stimulation of cardiac or skeletal receptors in research models.
This RUO-grade compound is offered as a 100mg oral tablet (30 count), manufactured by BlueBiotech® under controlled laboratory standards. With a purity of ≥99% (HPLC), it is ideal for non-human in vivo models investigating liver steatosis, cholesterol clearance, and metabolic disease mechanisms.
🔬 Learn more:
PubMed – Resmetirom in NASH and hepatic lipid studies
JCI – THR-β agonists and hepatic gene regulation
Key Features
✅ Selective THR-β agonist for metabolic and liver research
✅ 100mg oral tablet formulation – 30 tablets per bottle
✅ ≥99% purity (HPLC) for consistent and validated study outcomes
✅ Minimizes THR-α stimulation in cardiac tissue models
✅ Manufactured in the USA by BlueBiotech®
✅ RUO-compliant: Not for human or veterinary use
Specifications
Compound Name: Resmetirom (MGL-3196)
CAS Number: 922993-87-5
Molecular Formula: C₂₈H₃₄ClNO₃
Molecular Weight: 467.03 g/mol
Purity: ≥99% (HPLC)
Form: Off-white coated tablets
Content: 100mg per tablet × 30 tablets per bottle
Storage: Store in a cool, dry place; protect from light
Shelf Life: 24 months unopened
Use Classification: Research Use Only (RUO)
Research Applications
-
THR-β mediated lipid and cholesterol metabolism
-
Non-alcoholic fatty liver disease (NAFLD) and NASH modeling
-
Hepatic triglyceride reduction mechanisms
-
Thyroid receptor isoform selectivity studies
-
Endocrine signaling and liver-specific nuclear receptor regulation
⚠️ Compliance Statement
This product is strictly intended for research use only (RUO). It is not for use in humans or animals, and is not approved for clinical, diagnostic, or therapeutic applications.
All users are responsible for compliance with applicable laws and regulations in their jurisdictions.
Tags / Keywords
Resmetirom RUO, THR-β agonist, thyroid hormone analog, MGL-3196 tablets, liver fat research, BlueBiotech Research, metabolic disease model, NASH RUO compound, RUO oral tablets, lipid clearance study
Also in GLP-1 Peptides:
Similar Products
![Tirzep®-Tirzepatide Injection [ACI - Bangladesh]](https://www.bluebiotech.health/wp-content/uploads/2024/11/Tirzep-Tirzepatide-Injection-7.5-600x800.jpg)
Corporate Advantages
High-Purity Standards
Tested for purity and identity. COAs available
for all RUO compounds
Buyer Protection
Protected and discrete fulfillment
available upon request
Research-Grade Support
Dedicated service for labs, clinics, and
compounders handling RUO items.
Lab-Grade Quality Assurance
All compounds are tested for-identity and purity, COAs and supporting documentation are available upon request.
Strict RUO Compliance
All products are labeled for Researd Use Only (RUO), Not intended for human or veterinary therapeutic or diagnostic purposes.
Lab-Grade Quality Assurance
Custom branding.
white-label optionons and formulation assistancee available for eligible research institutions and partners.
Custom R&D & APl Synthesis
We support original
pharmaceutica solutions.custom research projects, and NDC-grade materials-meeting speifica.tions for qualified partners.
Serving Professionals Across the U.S.& Mexico
Trusted by MedSpas, wellness clinics and licensed compounders under licensed compounding relationships.
Secure & Discreet Fulfillment
Cold-chain shipping : private, plain.wrap packaging, and tracking for sensitive RUO materials.
⚠️ All compounds are provided strictly for Research Use Only (RUO). BLUEBIOTECH does not endorse or support clinical, therapeutic, or diagnostic use of its products unless under licensed compounder supervision.